Loading
institutionsInstitution
USC Norris Comprehensive Cancer Center
USC Norris was one of the first eight NCI comprehensive cancer centres in 1973; Peter Jones's work here on 5-azacytidine and DNA methylation founded cancer epigenetic therapy, Heinz-Josef Lenz leads its gastrointestinal and SWOG colorectal trials, and its Multiethnic Cohort Study tracks cancer risk across ethnic groups.
Overview
USC Norris was among the first eight centres to receive NCI comprehensive designation in 1973. Peter Jones's work here on 5-azacytidine and DNA methylation in the early 1980s founded the field of cancer epigenetic therapy. Heinz-Josef Lenz leads GI oncology and SWOG colorectal trials, and the Multiethnic Cohort Study run with the University of Hawai'i is one of the largest studies of cancer risk across ethnic groups. The centre serves Los Angeles County's diverse population and runs a broad early-phase trial programme.
Location
Los Angeles, CA, US
Type
cancer center · University of Southern California
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#133 · 35 points (0 Newsweek + 15 NCI + 20 from 10 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to USC Norris Comprehensive Cancer Center, including child institutions. 318 works · 3,917 citations · 72% open access · 17% clinical trials · 0% reviews.
Oncology works per year
572022
662023
612024
772025
572026
Most works
- Heinz‐Josef Lenz45 works
- Anthony B. El-Khoueiry31 works
- Jacob Thomas16 works
- Francesca Battaglin15 works
- Jorgé Nieva15 works
- Priya Jayachandran14 works
- Evanthia T. Roussos Torres14 works
- Shivani Soni12 works
- Gino K. In11 works
- Alan P. Venook11 works
Most cited
- Cancer epigenetics
- GI oncology (SWOG)
- Multiethnic Cohort Study
Similar pages
- TrialPBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS
Shares Azacitidine, Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TrialA Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
Shares Azacitidine, Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Acute myeloid leukaemia.
- TrialA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Shares Azacitidine, Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- PersonStephen B. Baylin
Shares Azacitidine, DNA methylation profiling, Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Acute myeloid leukaemia.
- TrialA Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy
Shares Azacitidine, Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Acute myeloid leukaemia.
- TrialA Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Shares Azacitidine, Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Acute myeloid leukaemia.
- TrialStudy to Evaluate the Safety and Tolerability of EP0042
Shares Azacitidine, Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TrialA Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
Shares Azacitidine, Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Myelodysplastic syndromes / neoplasms (MDS).
cancers
fronts
technologies
drugs
ApprovedSmall-molecule hypomethylating agent (cytotoxic)
Azacitidine · Vidaza / Onureg (oral)